Understanding the impact of PTMs, particularly phosphorylation, on LRRK2 is essential for unraveling the intricate molecular mechanisms contributing to Parkinsons disease, offering potential insights into therapeutic strategies targeting these specific modifications (Sonustun et al. 2022). Here, LRRK2 is linked to Parkinson disease.